About Techbankmed
Techbankmed is a Healthcare company based in Shanghai (China) founded in 2017. Auxiliary medical devices for cardiac interventional surgery are manufactured. Techbankmed has raised $14.93 million across 1 funding round from investors including Puhua Capital. Techbankmed offers products and services including SAFER Esophageal Retractor and Cardiovascular Innovation Services. Its focus areas include Traditional Medical Devices. Its legal entity in India is δΈζ΅·η§εΊε»ηζζ―ζιε ¬εΈ (U99999MH1977PLC010754).
Company details
Techbankmed was established in 2017 in Shanghai, China, as a manufacturer within the medical devices sector. Auxiliary devices designed for cardiac interventional surgery are produced, supporting procedures in healthcare settings. Operations are centered on development and production of these specialized tools, with a focus on the interventional cardiology field. The company serves markets through its domain, techbankmed.com, based in the Asia-Pacific region.
- Headquarters Shanghai, China
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website techbankmed.com
- Legal Name 上海科库医疗技术有限公司
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
- Total Equity Funding$14.93M (USD)
in 1 rounds
- Latest Funding Round$14.93M (USD), Series B
Jul 2022
- Investors
Associated legal entities of Techbankmed
Techbankmed operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of Techbankmed
Techbankmed offers a comprehensive portfolio of products and services, including SAFER Esophageal Retractor and Cardiovascular Innovation Services.
This device is used for esophageal retraction in medical procedures and was approved under special review processes.
Services for developing and commercializing cardiovascular technologies are provided through partnerships and intellectual property management.
Funding Insights of Techbankmed
Techbankmed has successfully raised a total of $14.93M through 1 strategic funding round. The most recent funding activity was a Series B round of $14.93 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.93M
- Total Rounds 1
- Last Round Series B β $14.93M
- First Round $14.93M
(Jul 2022)
- Investors Count 1
All 1 funding rounds of Techbankmed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $14.93M | Series B | β | Puhua Capital | β |
1 investors in total: 1 institutional.
Investors in Techbankmed
Techbankmed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Puhua Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health and technology startups are invested in by Puhua Capital. | puhuacapital.com | Hangzhou, China |
Investor details for Techbankmed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Techbankmed
2 dated milestones of Techbankmed across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Techbankmed is founded.
- Funding First funding round of $14.9M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Techbankmed
Complete news archive for Techbankmed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Techbankmed
Techbankmed was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Techbankmed is headquartered in Shanghai, China.
Techbankmed is a funded company, having raised a total of $14.93M across 1 funding round to date. The company's 1st funding round was a Series B of $14.93M, raised on Jul 2022.
Techbankmed was established in 2017 in Shanghai, China, as a manufacturer within the medical devices sector. Auxiliary devices designed for cardiac interventional surgery are produced, supporting procedures in healthcare settings. Operations are centered on development and production of these specialized tools, with a focus on the interventional cardiology field. The company serves markets through its domain, techbankmed.com, based in the Asia-Pacific region.
Techbankmed offers SAFER Esophageal Retractor and Cardiovascular Innovation Services.
Techbankmed has 1 investor. Key investors include Puhua Capital.
Techbankmed operates through ,.